Nom du produit:2,4-Dichloropyrimidine-5-carboxamide

IUPAC Name:2,4-dichloropyrimidine-5-carboxamide

CAS:1240390-28-6
Formule moléculaire:C5H3Cl2N3O
Pureté:97%
Numéro de catalogue:CM167387
Poids moléculaire:192

Unité d'emballage Stock disponible Prix($) Quantité
CM167387-5g in stock Ⱥƿ
CM167387-10g in stock ƿȐǶ
CM167387-25g in stock ȡƿƛ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1240390-28-6
Formule moléculaire:C5H3Cl2N3O
Point de fusion:-
Code SMILES:O=C(C1=CN=C(Cl)N=C1Cl)N
Densité:
Numéro de catalogue:CM167387
Poids moléculaire:192
Point d'ébullition:
N° Mdl:MFCD16658133
Stockage:Keep in dark place, inert atmosphere, store at 2-8°C.

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Cerdulatinib
Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. Cerdulatinib is a reversible ATP-competitive dual JAK and Syk inhibitor. The FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).